NEXT Biometrics Group ASA
NXTBF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $78,271 | $69,460 | $46,814 | $45,515 |
| - Cash | $5,526 | $6,652 | $7,065 | $11,632 |
| + Debt | $359 | $190 | $302 | $524 |
| Enterprise Value | $73,104 | $62,999 | $40,051 | $34,407 |
| Revenue | $6,287 | $3,310 | $4,741 | $5,639 |
| % Growth | 89.9% | -30.2% | -15.9% | – |
| Gross Profit | $85 | -$3,798 | -$2,824 | -$4,394 |
| % Margin | 1.4% | -114.7% | -59.6% | -77.9% |
| EBITDA | -$3,471 | -$5,730 | -$4,170 | -$5,666 |
| % Margin | -55.2% | -173.1% | -87.9% | -100.5% |
| Net Income | -$3,973 | -$6,453 | -$4,724 | -$6,797 |
| % Margin | -63.2% | -195% | -99.6% | -120.5% |
| EPS Diluted | -0.037 | -0.068 | -0.052 | -0.076 |
| % Growth | 45.3% | -31.7% | 32.4% | – |
| Operating Cash Flow | -$5,418 | -$5,560 | -$3,301 | -$5,400 |
| Capital Expenditures | -$52 | -$1 | -$7 | -$23 |
| Free Cash Flow | -$5,470 | -$5,561 | -$3,308 | -$5,423 |